NCT00800202 A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis Status COMPLETED Phase PHASE2
NCT00798603 Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00796991 Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine Status COMPLETED Phase PHASE1
NCT00795340 Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00793897 Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00793845 Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma Status COMPLETED Phase PHASE2
NCT00791154 QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00788125 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT00780494 Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma Status COMPLETED Phase PHASE2
NCT00780039 A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625) Status COMPLETED Phase PHASE2
NCT00769470 Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00768131 A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel Status WITHDRAWN Phase PHASE2
NCT00762034 A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00758732 Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma Status TERMINATED Phase PHASE2
NCT00756847 Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors Status COMPLETED Phase PHASE1
NCT00755313 Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer Status COMPLETED Phase N/A
NCT00753909 Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00753038 Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma Status COMPLETED Phase PHASE2